Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety and tolerance of SMOFlipid 20% in comparison
to a standard lipid emulsion Intralipid 20% in patients requiring long-term parenteral
nutrition. The safety and tolerance will be evaluated by biochemistry, hematology and
coagulation variables, vital signs and adverse events. Further objectives to evaluate are the
influence of SMOFlipid 20% on inflammation processes, the efficacy of anti-oxidative
properties of vitamin E supplemented to SMOFlipid 20%, and the fatty acid pattern in red
blood cells and serum.